| Line Item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Profit or loss [abstract] | ||||||
| Revenue | — | |||||
| Cost of Revenue | — | |||||
| Gross profit | — | |||||
| Research and Development Expense | ||||||
| Operating Income | ||||||
| Selling, General and Administrative Expense | ||||||
| Operating loss | ||||||
| Interest Expense | ||||||
| Interest Income | ||||||
| Income from Equity Method Investments | — | |||||
| Loss before income tax | ||||||
| Loss before tax for the year | ||||||
| Items that will not be reclassified to profit or loss: | ||||||
| Foreign currency translation | — | |||||
| Items that will or may be reclassified to profit or loss: | ||||||
| Foreign Currency Translation Adjustments | — | |||||
| Other comprehensive income (loss), net of tax | — | |||||
| Total comprehensive loss | ||||||
| Loss per share attributable to shareholders | ||||||
| Earnings Per Share (Basic) |